|
|
|
Insider
Information: |
Bentsur Ron |
Relationship: |
Chairman & CEO, Direct... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
4,188,470 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$53,268 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
4,188,470 |
|
|
Total
Value |
$53,268 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Keryx Biopharmaceuticals Inc |
KERX |
Chief Executive Office... |
2015-04-06 |
777,209 |
|
0 |
Premium* |
|
XTL Biopharmaceuticals Ltd |
XTLBY |
CEO |
2007-08-21 |
20,101 |
|
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Director |
2020-06-10 |
0 |
|
0 |
Premium* |
|
Beyond Air Ord Shs |
XAIR |
Director |
2023-03-20 |
144,736 |
|
0 |
Premium* |
|
Nuvectis Pharma, Inc. |
NVCT |
Chairman & CEO, Direct... |
2024-05-14 |
3,246,424 |
2022-02-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
152 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-11 |
4 |
AS |
$5.51 |
$21,553 |
D/D |
(3,910) |
233,110 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-12 |
4 |
AS |
$5.30 |
$24,834 |
D/D |
(4,689) |
228,421 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-13 |
4 |
AS |
$5.50 |
$22,494 |
D/D |
(4,088) |
224,333 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-14 |
4 |
AS |
$5.53 |
$36,932 |
D/D |
(6,680) |
217,653 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-17 |
4 |
AS |
$5.72 |
$25,226 |
D/D |
(4,413) |
213,240 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-18 |
4 |
AS |
$5.83 |
$26,691 |
D/D |
(4,578) |
208,662 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-19 |
4 |
AS |
$6.32 |
$41,266 |
D/D |
(6,533) |
202,129 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-20 |
4 |
AS |
$6.29 |
$23,780 |
D/D |
(3,778) |
198,351 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-21 |
4 |
AS |
$6.05 |
$19,651 |
D/D |
(3,246) |
195,105 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-24 |
4 |
AS |
$5.68 |
$22,104 |
D/D |
(3,889) |
191,216 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-25 |
4 |
AS |
$5.95 |
$9,406 |
D/D |
(1,580) |
189,636 |
0 |
- |
|
XTLBY |
XTL Biopharmaceuticals Lt... |
CEO |
|
2006-08-25 |
4 |
B |
$2.98 |
$4,768 |
D/D |
1,600 |
4,822 |
2.66 |
- |
|
XTLBY |
XTL Biopharmaceuticals Lt... |
CEO |
|
2007-08-21 |
4 |
B |
$1.30 |
$19,863 |
D/D |
15,279 |
20,101 |
2.74 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2009-05-22 |
4 |
B |
$0.37 |
$29,767 |
D/D |
80,000 |
286,661 |
2.74 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2009-06-23 |
4 |
B |
$0.90 |
$4,997 |
D/D |
5,560 |
292,221 |
2.73 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2011-08-10 |
4 |
B |
$3.05 |
$22,905 |
D/D |
7,500 |
359,281 |
2.81 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2012-04-18 |
4 |
B |
$1.29 |
$24,773 |
D/D |
19,100 |
479,476 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-02-04 |
4 |
B |
$3.89 |
$1,048,625 |
D/D |
212,500 |
2,777,959 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-02-07 |
4 |
B |
$3.93 |
$104,520 |
D/D |
20,000 |
2,797,959 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-02-10 |
4 |
B |
$6.34 |
$53,890 |
D/D |
8,500 |
2,806,459 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-02-14 |
4 |
B |
$5.88 |
$47,040 |
D/D |
8,000 |
2,814,459 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-03-17 |
4 |
B |
$7.63 |
$53,410 |
D/D |
7,000 |
2,821,459 |
3.23 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-03-28 |
4 |
B |
$7.05 |
$28,200 |
D/D |
4,000 |
2,825,459 |
3.23 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-05-12 |
4 |
B |
$14.88 |
$208,047 |
D/D |
12,245 |
2,957,704 |
3.23 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-05-13 |
4 |
B |
$18.10 |
$12,670 |
D/D |
700 |
2,958,404 |
3.15 |
- |
|
152 Records found
|
|
Page 2 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|